Karel Everaert

BOTULINUM TOXIN TYPE A IS A SAFE AND EFFECTIVE TREATMENT FOR NEUROGENIC URINARY INCONTINENCE: RESULTS OF A SINGLE TREATMENT, RANDOMIZED, PLACEBO CONTROLLED 6-MONTH STUDY

Brigitte Schurch, Marianne de Sèze, P. Denys et al. · The Journal of Urology · 2005 · 578 citations

Randomized, double‐blind placebo‐ and tolterodine‐controlled trial of the once‐daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder

Christopher R. Chapple, Tomasz Rechberger, P. J. MEFFAN et al. · British Journal of Urology · 2004 · 370 citations

International Continence Society consensus on the diagnosis and treatment of nocturia

Karel Everaert, François Hervé, Ruud Bosch et al. · Neurourology and Urodynamics · 2019 · 133 citations · Full text

A Prospective Randomized Trial Comparing the 1-Stage with the 2-Stage Implantation of a Pulse Generator in Patients with Pelvic Floor Dysfunction Selected for Sacral Nerve Stimulation

Karel Everaert, W. Kerckhaert, H. Caluwaerts et al. · European Urology · 2003 · 106 citations

Stimulation Device, Pulse Generator, Pelvic Floor Disorders +9

A proof‐of‐concept study: Mirabegron, a new therapy for overactive bladder

Christopher R. Chapple, G. Amarenco, López Aramburu et al. · Neurourology and Urodynamics · 2013 · 96 citations · Full text